.webp)
Leadgene Biomedical will deliver a featured presentation at the 16th Singapore Society of Nephrology Annual Scientific Meeting (SSN 2026).
Focusing on gut-derived uremic toxins, the session will explore the role of indoxyl sulfate (IS) in chronic kidney disease (CKD), including its potential as a complementary biomarker beyond conventional renal markers such as eGFR and albuminuria, as well as its emerging applications in translational research and clinical practice.
Event Details
- Topic | Indoxyl Sulfate in Chronic Kidney Disease: From Gut-Derived Uremic Toxin to Translational Biomarker
- Speaker | Dr. Ping-Hsun Wu, MD, PhD
Attending Physician, Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital
Clinical Associate Professor, Kaohsiung Medical University, Taiwan
- Moderator | Prof. Angela Yee-Moon Wang, MD, PhD
Senior Consultant, Renal Medicine, Singapore General Hospital
Clinical Professor, Duke-NUS Medical School, Singapore
- Date: September 27, 2026 (Sun)
- Time: 10:10–11:00 AM (Tea Symposium 2)
- Venue: Hilton Singapore Orchard
We invite you to join us and explore the latest developments in CKD biomarkers and translational research. We look forward to seeing you in Singapore!
Privacy Notice for SSN 2026 Symposium Registration
Leadgene Biomedical, Inc. respects your privacy.
The personal information provided via this form (including name, email, job title, and institution) will be used for the purpose of managing your registration for the SSN Tea Symposium 2026, providing event updates, and sharing relevant medical communications, kidney care educational materials, product flyers, and industry updates from Leadgene.
We will not sell or lease your personal information to third parties. You may request to update, access, or delete your personal data, or unsubscribe from future communications at any time by contacting us at [email protected].
